These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32669514)

  • 41. Probable sarcopenia: associations with common geriatric syndromes and comorbidities in Turkish geriatric patients from a university hospital.
    Erbas Sacar D; Kılıc C; Oren MM; Erdogan T; Ozkok S; Ozer Aydın C; Catikkas NM; Karan MA; Bahat G
    Eur Geriatr Med; 2022 Dec; 13(6):1299-1308. PubMed ID: 36029439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between osteosarcopenia and cognitive frailty in older outpatients visiting a frailty clinic.
    Inoue T; Shimizu A; Satake S; Matsui Y; Ueshima J; Murotani K; Arai H; Maeda K
    Arch Gerontol Geriatr; 2022; 98():104530. PubMed ID: 34562795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlations between Depressive Condition and Gastroesophageal Reflux Symptoms in Patients Visiting a Department of General Medicine.
    Suganami Y; Oka K; Hanayama Y; Honda H; Hamahara J; Obika M; Kariyama K; Kishida M; Otsuka F
    Acta Med Okayama; 2019 Dec; 73(6):479-486. PubMed ID: 31871329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study.
    Suzuki T; Matsushima M; Masui A; Tsuda S; Imai J; Nakamura J; Tsukune Y; Uchida T; Yuhara H; Igarashi M; Koike J; Mine T
    World J Gastroenterol; 2015 Apr; 21(16):5023-31. PubMed ID: 25945018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination of PPI with a prokinetic drug in gastroesophageal reflux disease.
    Ndraha S
    Acta Med Indones; 2011 Oct; 43(4):233-6. PubMed ID: 22156354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term follow up in patients with gastroesophageal reflux disease with specific emphasis on reflux symptoms, use of anti-reflux medication and anti-reflux surgery outcome: a retrospective study.
    Van Meer S; Bogte A; Siersema PD
    Scand J Gastroenterol; 2013 Nov; 48(11):1242-8. PubMed ID: 24041112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of spinal kyphosis on gastroesophageal reflux disease symptoms in patients with osteoporosis.
    Miyakoshi N; Kasukawa Y; Sasaki H; Kamo K; Shimada Y
    Osteoporos Int; 2009 Jul; 20(7):1193-8. PubMed ID: 18949531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan.
    Shinozaki S; Osawa H; Kobayashi Y; Sakamoto H; Hayashi Y; Miura Y; Kawarai Lefor A; Yamamoto H
    Scand J Gastroenterol; 2018 Aug; 53(8):897-904. PubMed ID: 30056768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship of the frequency scale for symptoms of gastroesophageal reflux disease with endoscopic findings of cardiac sphincter morphology.
    Tsuboi K; Omura N; Yano F; Kashiwagi H; Yanaga K
    J Gastroenterol; 2008; 43(10):798-802. PubMed ID: 18958549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Scoring of reflux symptoms associated with scleroderma and the usefulness of rabeprazole.
    Muro Y; Sugiura K; Nitta Y; Mitsuma T; Hoshino K; Usuda T; Hayashi K; Murase Y; Shimizu M; Matsuo H
    Clin Exp Rheumatol; 2009; 27(3 Suppl 54):15-21. PubMed ID: 19796556
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid Geriatric Assessment, Physical Activity, and Sleep Quality in Adults Aged more than 65 Years: A Preliminary Study.
    Tuna F; Üstündağ A; Başak Can H; Tuna H
    J Nutr Health Aging; 2019; 23(7):617-622. PubMed ID: 31367725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
    Raghunath AS; Hungin AP; Mason J; Jackson W
    Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factors associated with the prevalence of sarcopenia and frailty syndrome in elderly university workers.
    de Amorim JSC; da Silva SLA; Ude Viana J; Trelha CS
    Arch Gerontol Geriatr; 2019; 82():172-178. PubMed ID: 30807901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
    van Pinxteren B; Sigterman KE; Bonis P; Lau J; Numans ME
    Cochrane Database Syst Rev; 2010 Nov; (11):CD002095. PubMed ID: 21069670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres.
    Danjo A; Yamaguchi K; Fujimoto K; Saitoh T; Inamori M; Ando T; Shimatani T; Adachi K; Kinjo F; Kuribayashi S; Mitsufuji S; Fujiwara Y; Koyama S; Akiyama J; Takagi A; Manabe N; Miwa H; Shimoyama Y; Kusano M
    J Gastroenterol Hepatol; 2009 Apr; 24(4):633-8. PubMed ID: 19220681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
    Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship Between Sarcopenia and Frailty in the Toledo Study of Healthy Aging: A Population Based Cross-Sectional Study.
    Davies B; García F; Ara I; Artalejo FR; Rodriguez-Mañas L; Walter S
    J Am Med Dir Assoc; 2018 Apr; 19(4):282-286. PubMed ID: 29079029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frailty and sarcopenia in Bogotá: results from the SABE Bogotá Study.
    Samper-Ternent R; Reyes-Ortiz C; Ottenbacher KJ; Cano CA
    Aging Clin Exp Res; 2017 Apr; 29(2):265-272. PubMed ID: 27034288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Can Sarcopenia Quantified by Ultrasound of the Rectus Femoris Muscle Predict Adverse Outcome of Surgical Intensive Care Unit Patients as well as Frailty? A Prospective, Observational Cohort Study.
    Mueller N; Murthy S; Tainter CR; Lee J; Riddell K; Fintelmann FJ; Grabitz SD; Timm FP; Levi B; Kurth T; Eikermann M
    Ann Surg; 2016 Dec; 264(6):1116-1124. PubMed ID: 26655919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.